钆塞酸二钠增强磁共振成像预测肝内肿块型胆管癌术后预后
回顾性分析54例肝内肿块型胆管癌患者的术前钆塞酸二钠增强MRI,采用Cox回归筛选与无复发生存和总生存相关的影像及病理特征。影像模型中包膜穿透和肿瘤大小是无复发生存更差的独立标志,包膜穿透和肝静脉阻塞是总生存更差的独立标志;联合包膜穿透的模型较单纯病理模型C-index更高、AIC更低。
要点
- MRI显示包膜穿透和肝静脉阻塞提示肝内肿块型胆管癌术后预后更差。
- 包膜穿透是无复发生存的独立影像标志,联合模型预测效能优于单纯病理模型。
- 肿瘤大小与无复发生存独立相关,肝静脉阻塞与总生存独立相关。
核心结论
- MRI上的包膜穿透和肝静脉阻塞是肝内肿块型胆管癌术后结局的显著不良影像预后因素。
- 将包膜穿透和肝静脉阻塞纳入外科分期系统可能改善对肝内肿块型胆管癌术后预后的预测。
研究设计与样本
- 回顾性评估54例接受术前钆塞酸二钠增强MRI并行根治性手术的肝内肿块型胆管癌患者。
- 采用Cox回归模型分析与无复发生存和总生存相关的影像及病理特征。
- 构建联合影像与病理特征的模型,采用Harrell C-index和Akaike信息准则评价其效能。
关键影像表现/征象
- 影像模型中包膜穿透(P = 0.016)和肿瘤大小(P = 0.015)是无复发生存更差的独立标志。
- 影像模型中包膜穿透(P = 0.012)和肝静脉阻塞(P = 0.016)是总生存更差的独立标志。
- 包膜穿透是无复发生存联合预测模型中唯一的影像标志。
- 联合模型较单纯病理特征模型C-index更高、AIC值更低。
诊断标准与关键数值
- 包膜穿透预测无复发生存更差的Cox回归P = 0.016。
- 肿瘤大小预测无复发生存更差的Cox回归P = 0.015。
- 包膜穿透预测总生存更差的Cox回归P = 0.012。
- 肝静脉阻塞预测总生存更差的Cox回归P = 0.016。
临床应用与阅片要点
- 阅片时注意评估肿瘤包膜穿透和肝静脉阻塞,这两项影像征象与术后预后更差独立相关。
- 联合模型较单纯病理模型C-index更高、AIC更低,提示影像特征可补充病理特征用于术后预后预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To identify imaging markers that independently predict the post-operative outcome of intrahepatic mass-forming cholangiocarcinoma (IMCC) using gadoxetate disodium-enhanced magnetic resonance imaging (MRI).
METHODS: Data from 54 patients who underwent pre-operative gadoxetate disodium-enhanced MRI and curative surgery for IMCC were retrospectively evaluated. The prognostic power of various imaging and pathological features reportedly associated with recurrence-free survival (RFS) and overall survival (OS) was analyzed using Cox regression models. A model combining imaging and pathological features was developed and its performance was evaluated using the Harrell C-index and Akaike information criterion.
RESULTS: Capsule penetration (P = 0.016) and tumor size (P = 0.015) were independent markers for worse RFS, while capsule penetration (P = 0.012) and hepatic vein obstruction (HVO, P = 0.016) were independent markers for worse OS, respectively, in the imaging-based model. Capsule penetration was the only imaging marker identified in the combined prediction model of RFS, and the combined model showed a higher C-index and lower AIC value compared with the model based on pathological features alone.
CONCLUSIONS: Capsule penetration and HVO on MRI are significantly worse imaging prognostic factors for post-operative outcomes in patients with IMCC. Incorporation of capsule penetration and HVO into a surgical staging system may improve prediction of the post-operative prognosis of IMCC.
引用
- Kim S, An C, Han K, et al. Gadoxetic acid enhanced magnetic resonance imaging for prediction of the postoperative prognosis of intrahepatic mass-forming cholangiocarcinoma. Abdom Radiol (NY). 2019. PMID: 30078083. doi:10.1007/s00261-018-1727-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。